HDVY- up 12.5% to .18 on massive volume spike today. 2 days ago, the company settled (hopefully for good) the nefarious "note M" in an old filing which could have diluted (worst case scenario) the company to the tune of a billion shares. From the 10-K, {Note M):
if we are unsuccessful in defending against the claims, the Company may be required, among other things, to issue approximately 146,664,375 shares to such investor, and, if all of the other investors in the 2007 Private Placement sought the same remedy, the Company may be required to issue approximately 1,099,494,872 shares in the aggregate. Issuing any significant portion of such shares of Common Stock would cause substantial dilution to existing shareholders[my emphasis
The company has deals with Abbott and Quest for its urine based prostate cancer test using the same technology that Vermillion uses. (Vermillion bought the license from HDVY)
The urine test is past the anticipated due date by some months now. Settlement of note M along with a major Quest player joining the HDVY team strongly suggest that either a buyout is in the works or the urine based test is ready to launch soon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.